Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Small Cell Lung Carcinoma 9Burkitt Lymphoma 7Lung Neoplasms 6Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Sarcoma, Ewing 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Plasmablastic Lymphoma 3Multiple Myeloma 3Lymphoma 3Leukemia 3Hodgkin Disease 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Myelodysplastic Syndromes 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Immunoblastic Lymphadenopathy 2HIV Infections 2Ganglioneuroblastoma 2Congenital Abnormalities 2Blast Crisis 2Anemia, Refractory, with Excess of Blasts 2Wilms Tumor 1

Interventions

Magnetic Resonance Spectroscopy 6X-Rays 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Specimen Handling 4Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2Temozolomide 2Cyclophosphamide 2Cisplatin 2tazemetostat 1palbociclib 1lutetium Lu 177 dotatate 1Vemurafenib 1Vascular Endothelial Growth Factor A 1Triiodothyronine 1Thiotepa 1Radiotherapy 1Radiation 1Platinum 1Pharmacogenomic Variants 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Etoposide × 30 days × Clear all
NCT02875314 2026-06-03

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Nationwide Children's Hospital

Phase 4 Active not recruiting
250 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡